A second confirmatory trial of MPC-150-IM in patients with chronic heart failure
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2016
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 12 Oct 2016 According to a Mesoblast media release, results from this trial with data in a limited number of Japanese patients could support Japanese regulatory filings and product launch.
- 25 Aug 2016 According to a Mesoblast media release,the company plans to assess interim analysis to assess the primary endpoint between cell-treated and control patients in the first quarter of 2017.
- 25 Aug 2016 According to a Mesoblast media release, status changed from planning to recruiting.